Zinzino Acquires Valentus Global in a strategic move to strengthen its position in the global wellness industry. The Scandinavian-based wellness giant has officially taken over key assets of the US/UK direct selling company, including its distributor network, product inventory, customer database, and intellectual property rights. This acquisition marks another major step in Zinzino’s global expansion roadmap.
Zinzino’s acquisition aligns with its mission of improving personal health and wellness across the world through innovative biotechnology and personalized nutrition products. Valentus Global, founded in Delaware, USA, has built a strong presence in Europe and North America with its wellness, nutrition, and health products.
This move gives Zinzino access to a new customer base, new markets, and a complementary product line that supports its long-term growth strategy.
According to Zinzino’s CEO Dag Bergheim Pettersen, the future of wellness lies in personalized solutions backed by technology. He believes this partnership will enable both companies to deliver a more customized customer experience through direct selling.
Over the past few years, Zinzino has made several important acquisitions to fuel its growth and market expansion. These include:
VMA Life in 2020
Enhanzz in 2022
Xelliss & ACN in 2024
Zurvita (asset acquisition) in early 2025
Valentus Global in 2025
Each of these deals has helped Zinzino expand its product offerings, strengthen its distribution network, and enter new markets.
The deal between Zinzino and Valentus Global was valued at SEK 20 Million (approximately $1.8 Million USD). Out of this total, SEK 10 Million (roughly $0.9 Million USD) was the estimated value of Valentus Global’s inventory.
The payment was made in full cash, financed directly from Zinzino’s own funds. This shows the company’s strong financial position and commitment to sustainable, debt-free growth.
Valentus Global had recorded sales of over SEK 50 Million (around $4.5 Million USD) last year, with most of its operations focused in Europe and North America.
By acquiring Valentus Global, Zinzino aims to strengthen its presence in Europe and North America, expand its distributor base, and leverage Valentus Global’s product innovation.
This merger will also allow both companies to create synergies by combining their distributor networks and resources. Moreover, Valentus Global’s technology-driven and nutrition-focused approach fits well with Zinzino’s strategy of offering test-based, personalized wellness solutions.
Zinzino is a Scandinavian direct selling company specializing in personalized nutrition and scientific skincare products. The company operates in over 100 markets across the globe and is listed on the Nasdaq First North Premier Growth Market.
Its product portfolio is based on test-based nutrition, cellular-level health solutions, and science-backed skincare. Apart from its nutrition products, Zinzino also owns the Swiss skincare brand HANZZ+HEIDII and Norwegian research units BioActive Foods AS and Faun Pharma AS.
Headquartered in Gothenburg, Sweden, Zinzino has additional offices in Europe, Asia, the US, and Australia.
There are no reviews yet. Be the first one to write one.
